Envista Holdings Co. (NYSE:NVST) Shares Purchased by Hudson Edge Investment Partners Inc.

Hudson Edge Investment Partners Inc. boosted its holdings in shares of Envista Holdings Co. (NYSE:NVST) by 4.8% in the 4th quarter, Holdings Channel.com reports. The fund owned 24,931 shares of the company’s stock after buying an additional 1,150 shares during the quarter. Hudson Edge Investment Partners Inc.’s holdings in Envista were worth $481,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Mirae Asset Global Investments Co. Ltd. purchased a new stake in Envista in the 3rd quarter valued at about $31,000. Huntington National Bank increased its position in shares of Envista by 97.8% during the third quarter. Huntington National Bank now owns 1,919 shares of the company’s stock valued at $38,000 after acquiring an additional 949 shares during the last quarter. Venturi Wealth Management LLC raised its stake in shares of Envista by 528.4% in the 4th quarter. Venturi Wealth Management LLC now owns 1,948 shares of the company’s stock valued at $38,000 after acquiring an additional 1,638 shares during the period. Blue Trust Inc. lifted its holdings in shares of Envista by 69.7% in the 3rd quarter. Blue Trust Inc. now owns 1,957 shares of the company’s stock worth $39,000 after acquiring an additional 804 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC lifted its holdings in shares of Envista by 50.8% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 2,161 shares of the company’s stock worth $43,000 after acquiring an additional 728 shares during the last quarter.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on NVST. Leerink Partners raised Envista from an “underperform” rating to a “market perform” rating and boosted their target price for the company from $16.00 to $23.00 in a research report on Thursday, October 31st. Morgan Stanley boosted their price objective on Envista from $19.00 to $20.00 and gave the company an “equal weight” rating in a report on Thursday, February 6th. Robert W. Baird raised their target price on Envista from $17.00 to $22.00 and gave the company a “neutral” rating in a report on Thursday, October 31st. Piper Sandler boosted their price target on shares of Envista from $17.00 to $18.00 and gave the stock a “neutral” rating in a research note on Monday, February 3rd. Finally, Wells Fargo & Company increased their price target on shares of Envista from $20.00 to $21.00 and gave the stock an “equal weight” rating in a research report on Thursday, February 6th. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $20.21.

Envista Stock Down 2.5 %

Shares of Envista stock opened at $20.91 on Friday. The company has a quick ratio of 1.76, a current ratio of 2.04 and a debt-to-equity ratio of 0.44. Envista Holdings Co. has a 52-week low of $15.15 and a 52-week high of $23.06. The company has a market capitalization of $3.60 billion, a P/E ratio of -3.22, a P/E/G ratio of 1.29 and a beta of 1.34. The company has a 50 day moving average of $20.11 and a 200 day moving average of $19.50.

Envista (NYSE:NVST) last released its quarterly earnings data on Wednesday, February 5th. The company reported $0.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.23 by $0.01. Envista had a negative net margin of 44.56% and a positive return on equity of 3.86%. As a group, research analysts forecast that Envista Holdings Co. will post 1 EPS for the current fiscal year.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.